|
|
|
|
||||
|
||||
Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased OversightKathleen BoozangSeton Hall School of Law; Seton Hall University - Center for Health & Pharmaceutical Law & Policy Carl H. ColemanSeton Hall University School of Law Tracy E. MillerSeton Hall University - Center for Health & Pharmaceutical Law & Policy Kate GreenwoodSeton Hall University - School of Law - Center for Health & Pharmaceutical Law & Policy Valerie Gutmann KochIllinois Institute of Technology - Chicago-Kent College of Law; New York State Task Force on Life and the Law Simone Handler-HutchinsonCenter for Health & Pharmaceutical Law & Policy; Seton Hall School of Law Catherine FinizioSeton Hall University - Center for Health & Pharmaceutical Law & Policy November 30, 2009 White Paper for the Center for Health & Pharmaceutical Law & Policy, Seton Hall Law School Abstract: This White Paper makes several policy recommendations to eliminate or manage the conflicts of interest that arise pursuant to the compensation arrangements between investigators and their institutions with drug and medical device manufacturers as they affect the recruitment and enrollment of human research subjects in clinical trials. The paper seeks to accomplish overall financial neutrality as between treatment and research, so that physicians' decisions regarding inclusion of patients in clinical trials is unaffected by their own financial interests.
Number of Pages in PDF File: 62 Keywords: conflict of interest, pharmaceutical, clinical trials working papers seriesDate posted: December 3, 2009 ; Last revised: March 24, 2010Suggested CitationContact Information
|
|
|||||||||||||||||||||||||||||||||||
© 2013 Social Science Electronic Publishing, Inc. All Rights Reserved.
FAQ
Terms of Use
Privacy Policy
Copyright
This page was processed by apollo7 in 0.548 seconds
